Aardvark Therapeutics (AARD) Total Current Liabilities (2024 - 2026)
Aardvark Therapeutics (AARD) reported Total Current Liabilities of $11.6 million for Q1 2026, up 94.18% on a YoY basis from $6.0 million in Q1 2025, and up 10.01% sequentially from $10.5 million in Q4 2025.
Aardvark Therapeutics (AARD) Total Current Liabilities (2024 - 2026) Analysis & Trends
Aardvark Therapeutics (AARD) has 3 years of Total Current Liabilities data on file, last reported at $11.6 million in Q1 2026.
- For the quarter ending Q1 2026, Total Current Liabilities rose 94.18% year-over-year to $11.6 million; the trailing twelve-month figure through Mar 2026 stood at $11.6 million (up 94.18% YoY), and the FY2025 full-year result was $10.5 million, up 114.09% from the prior year.
- Total Current Liabilities climbed to $11.6 million in Q1 2026, from $10.5 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $11.6 million in Q1 2026 to a low of $4.9 million in Q4 2024.
- A 3-year average of $9.0 million and a median of $10.4 million in 2025 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities soared 114.09% in 2025 and jumped 94.18% in 2026, its largest moves.
- Tracing AARD's Total Current Liabilities over 3 years: stood at $4.9 million in 2024, then soared by 114.09% to $10.5 million in 2025, then gained by 10.01% to $11.6 million in 2026.
- Business Quant data shows AARD's Total Current Liabilities at $11.6 million in Q1 2026, $10.5 million in Q4 2025, and $10.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 56.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 66.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.81 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 6.38 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 3.88 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.11 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 289.60 Mn |
| 10 | Aardvark Therapeutics | 139.40 Mn | 19.44 Mn | - | 11.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.60 Mn |
| Dec 31, 2025 | 10.55 Mn |
| Sep 30, 2025 | 10.74 Mn |
| Jun 30, 2025 | 10.31 Mn |
| Mar 31, 2025 | 5.98 Mn |
| Dec 31, 2024 | 4.93 Mn |